PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q2 EPS of ($0.35), $0.06 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $79.2 million versus the consensus estimate of $76.12 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.